VISION
The primary aim of ISGCT is to collaborate scientists, physicians, patients, regulatory authorities and industry on one platform to evaluate the progress made in the field of stem cell and gene research, treatment and results. We will be showcasing cutting edge technologies such as DNA amplification, disease identification through next gene sequencing, genome editing and autologous DNA and stem cell therapy.